Expert Testimony
Opposing the Colorado Board of Health Proposed Rules for Allowing Greater than 0.3% THC Hemp Products
Adult Use (cannabis)
date
11/16/23
Expert Testimony
Opposing Maryland’s Cannabis-induced Psychosis and THC Concentration Limit (HB 23-1147)
Medical (cannabis)
date
3/1/23
Expert Testimony
Supporting Hawaii’s Adult Use Cannabis Program (SB375)
Adult Use (cannabis)
date
2/17/23
D4DPR Updates
D4DPR Publishes White Paper on Legislating Cannabis Use in Healthcare Facilities
Medical (cannabis)
date
2/17/23
Expert Testimony
Supporting Colorado’s Access to Medical Marijuana (SB-081)
Medical (cannabis)
date
2/17/23
Expert Testimony
Supporting Maryland’s Adult Use Cannabis Program (HB556)
Medical (cannabis)
date
2/16/23
Expert Testimony
Supporting Delaware’s Adult Use Cannabis Program (HB 23-2)
Adult Use (cannabis)
date
1/24/23
Expert Testimony
Supporting Kansas’ Medical Cannabis Program (SB 560)
Medical (cannabis)
date
6/29/22
Expert Testimony
Supporting Override of Delaware’s Governor Veto of Adult Use Cannabis Program (HB 371)
Adult Use (cannabis)
date
6/2/22
Expert Testimony
Supporting the U.S. House Ending the Federal Prohibition of Cannabis - The MORE Act
date
2/24/22
Expert Testimony
Supporting Delaware’s Adult Use Cannabis Program (HB 305)
Adult Use (cannabis)
date
1/26/22
Expert Testimony
Supporting the U.S. House Ending the Federal Prohibition of Cannabis - The MORE Act
date
10/1/21
Expert Testimony
Testimony to New Jersey’s Cannabis Regulatory Commission
Regulatory (cannabis)
date
6/2/21
Expert Testimony
Opposing Colorado’s Cannabis Potency Cap (HB 21-1317)
Regulatory (cannabis)
date
5/18/21
Expert Testimony
Supporting Alabama’s Medical Cannabis Program (SB 46)
Medical (cannabis)
date
4/26/21
Expert Testimony
Supporting Texas’ Penalty Reduction for Cannabis Possession (HB 3772)
Penalty Reduction (cannabis)
Bryon Adinoff, MD
date
4/20/21
Expert Testimony
Supporting Delaware’s Adult Use Cannabis Program (HB 150)
Adult Use (cannabis)
Bryon Adinoff, MD
date
3/24/21
Expert Testimony
Supporting Delaware’s Adult Use Cannabis Program (HB 150)
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
3/24/21
Expert Testimony
Supporting Connecticut’s Adult Use Cannabis Program (SB 888)
Regulatory (cannabis)
Hugh Blumenfeld, MD, PhD
date
3/1/21
Expert Testimony
Supporting Connecticut’s Adult Use Cannabis Program (SB 888)
Adult Use (cannabis)
Bryon Adinoff, MD
date
2/25/21
Expert Testimony
New York Legislature CRTA
Medical (cannabis)
Tanya Adams, DO
date
2/23/21
Expert Testimony
New Jersey Senate Judiciary AB1898
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
2/22/21
Expert Testimony
Virginia Senate: Adult Use Cannabis
Adult Use (cannabis)
Bryon Adinoff, MD
date
1/31/21
Expert Testimony
Comments in Response to the Cannabis Administration and Opportunity Act (CAOA)
Adult Use (cannabis)
date
1/1/21
Expert Testimony
US Senate Cannabis Administration and Opportunity Act
Regulatory (cannabis)
date
1/1/21
Expert Testimony
New Jersey Assembly Appropriations: Regulations
Regulatory (cannabis)
David L. Nathan, MD, DFAPA
date
11/20/20
Expert Testimony
New Jersey Assembly Oversight, Reform and Federal Relations
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
11/10/20
Expert Testimony
Connecticut Senate Judiciary SB16
Adult Use (cannabis)
Bryon Adinoff, MD
date
3/3/20
Expert Testimony
Connecticut Senate Judiciary SB16
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
3/3/20
Expert Testimony
US House Subcommittee Cannabis Policies for the New Decade
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
1/18/20
Expert Testimony
Alabama House SB165
Medical (cannabis)
date
1/1/20
Expert Testimony
Alabama House SB165
Medical (cannabis)
date
1/1/20
Expert Testimony
Alabama House SB165
Medical (cannabis)
date
1/1/20
Expert Testimony
New Jersey General Assembly CR840
Monica Taing, PharmD
date
12/12/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Medical (cannabis)
Bryon Adinoff, MD
date
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Medical (cannabis)
Wendy Askew, MD
date
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Medical (cannabis)
Rachel Knox, MD
date
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Medical (cannabis)
Genester Wilson-King, MD, FACOG
date
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Medical (cannabis)
Donald O. Lyman, MD, DTPH
date
10/23/19
Expert Testimony
U.S. House: Congressional Committee Hearing on Cannabis Legalization
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
7/10/19
Expert Testimony
Delaware House Revenue & Finance HB110
Adult Use (cannabis)
Bryon Adinoff, MD
date
6/5/19
Expert Testimony
Colorado Senate Medical Marijuana Code SB218
Medical (cannabis)
date
5/10/19
Expert Testimony
Vermont House Government Operations SB54
Regulatory (cannabis)
David L. Nathan, MD, DFAPA
date
4/30/19
Expert Testimony
South Carolina Medical Affairs S.366
Medical (cannabis)
Bryon Adinoff, MD
date
4/6/19
Expert Testimony
South Carolina Medical Affairs S.366
Medical (cannabis)
date
4/1/19
Expert Testimony
New Jersey Senate Judiciary SB2703
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
3/19/19
Expert Testimony
Texas House Public Health HB1365
Medical (cannabis)
Bryon Adinoff, MD
date
3/16/19
Expert Testimony
Texas House Criminal Jurisprudence HB63
Penalty Reduction (cannabis)
Bryon Adinoff, MD
date
3/4/19
Expert Testimony
Vermont Senate Judiciary SB54
David L. Nathan, MD, DFAPA
date
2/1/19
Expert Testimony
New York General Assembly
Adult Use (cannabis)
date
12/1/18
Expert Testimony
New Jersey Senate Judiciary SB2703
Adult Use (cannabis)
date
11/1/18
Expert Testimony
New York Assembly Codes, Health, Governmental Operations, Alcoholism and Drug Abuse
Regulatory (cannabis)
David L. Nathan, MD, DFAPA
date
10/17/18
Expert Testimony
Connecticut Commission on Women, Children and Seniors Cannabis Forum (Video)
David L. Nathan, MD, DFAPA
date
4/30/18
Expert Testimony
New Jersey Division of Consumer Affairs Marijuana Reclassification
Regulatory (cannabis)
David L. Nathan, MD, DFAPA
date
4/25/18
Expert Testimony
U.S. FDA Cannabis Scheduling
Regulatory (cannabis)
David L. Nathan, MD, DFAPA
date
4/23/18
Expert Testimony
New Jersey Assembly Oversight, Reform and Federal Relations Committee on Cannabis Legalization
David L. Nathan, MD, DFAPA
date
3/6/18
Expert Testimony
Illinois General Assembly SB316
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
1/23/18
Expert Testimony
Testimony before the Illinois Senate on Marijuana Legalization
date
1/22/18
Expert Testimony
New Jersey Senate Judiciary Cannabis Adult Use
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
6/19/17
Expert Testimony
Delaware House Revenue & Finance HB110
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
5/11/17
Expert Testimony
Texas House Criminal Jurisprudence HB2107
Penalty Reduction (cannabis)
Bryon Adinoff, MD
date
5/3/17
Expert Testimony
California State Assembly AB1606
Regulatory (cannabis)
D4DPR
date
4/14/17
Expert Testimony
Vermont House Human Services H.170
Adult Use (cannabis)
Bryon Adinoff, MD
date
4/12/17
Expert Testimony
Rhode Island House Judiciary HB5555
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
4/12/17
Expert Testimony
Texas House Criminal Jurisprudence HB81
Penalty Reduction (cannabis)
Bryon Adinoff, MD
date
3/14/17
Expert Testimony
New Jersey Senate Judiciary
Adult Use (cannabis)
David L. Nathan, MD, DFAPA
date
11/17/15

Browse by Location

Alabama
California
Colorado
Connecticut
Delaware
Federal
Hawaii
Illinois
International
Kansas
Maryland
Montana
New Jersey
New York
Pennsylvania
Rhode Island
South Carolina
Texas
Vermont
Virginia

Browse by Topic

Opioids
Harm Reduction
Psychedelics
Penalty Reduction (cannabis)
Regulatory (cannabis)
Medical (cannabis)
Adult Use (cannabis)